Octagon Capital Advisors LP Annexon, Inc. Transaction History
Octagon Capital Advisors LP
- $414 Million
- Q3 2024
A detailed history of Octagon Capital Advisors LP transactions in Annexon, Inc. stock. As of the latest transaction made, Octagon Capital Advisors LP holds 400,000 shares of ANNX stock, worth $1.7 Million. This represents 0.57% of its overall portfolio holdings.
Number of Shares
400,000
Previous 400,000
-0.0%
Holding current value
$1.7 Million
Previous $1.96 Million
20.82%
% of portfolio
0.57%
Previous 0.45%
Shares
4 transactions
Others Institutions Holding ANNX
# of Institutions
147Shares Held
103MCall Options Held
178KPut Options Held
159K-
Bain Capital Life Sciences Investors, LLC Boston, MA8.45MShares$36 Million8.98% of portfolio
-
Satter Management Co., L.P.7.41MShares$31.5 Million76.44% of portfolio
-
Bvf Inc San Francisco, CA7MShares$29.8 Million1.32% of portfolio
-
Black Rock Inc. New York, NY6.59MShares$28.1 Million0.0% of portfolio
-
Redmile Group, LLC San Francisco, CA6.43MShares$27.4 Million2.49% of portfolio
About Annexon, Inc.
- Ticker ANNX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 47,617,700
- Market Cap $203M
- Description
- Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. The company's C1q is an initiating molecule of the classical complement pathway that targets distinct disease processes, such as antibody-mediated autoimmune disease and complement-mediated n...